Systems Biology of Drug Perturbations
Combining and integrating different types of data (e.g.,
molecular in vitro data, data from cell-based assays, complex
phenotypic data such as side effects), we aim at gaining a better
understanding of drug mechanisms of action. Ideally, this will aid
the interpretation of drug action in many contexts, from the
molecular level (for instance, drug-target interaction) to the whole
organism (e.g., establishing links between side effects and cellular
pathways: Brouwers
et al. PLoS One, 2011; see also Iskar et
al. Curr. Opin. Biotechnol., 2011). To this end, we develop
methods to predict protein targets, response pathways or side
effects of drugs from complex cell-based assays or organism-scale
data and analyze these predictive models to reveal the underlying
biological mechanisms. We see this as rational approaches to drug
repositioning and in silico drug safety assessment.
Currently, we focus on cellular assays of expression changes upon chemical perturbations: The Connectivity Map records gene expression (for >10,000 genes) in several cell lines for hundreds of small molecules. Analysis of such complex multi-parametric read-outs requires intelligent data reduction and feature selection techniques in order to derive predictive molecular signatures of drug action. Ideally, these molecular signatures will facilitate interpretation in a cellular context and help establish links to organismal phenotypes.
SIDER resource at EMBL | STITCH resource at EMBL | CMap project at the BROAD